Royston Instruments Announces Acquisition of Controlling Stake in Biosan, Strengthening Global Life-Science and Laboratory Instrumentation Capabilities Royston, United Kingdom, 19th March 2026, Royston Instruments Ltd, a diversified technology group focused on advancing scientific instrumentation and data acquisition solutions, today announced that it has acquired a controlling stake in Biosan SIA, the Riga-based developer and manufacturer [...]

ViaPlex™ enables fluorescent barcoding of up to 15 cell populations in a single tube to reduce reagent use, save time, and increase throughput for flow cytometry workflows. FREMONT, CA -- Biotium, a leading provider of fluorescent reagents and kits for life science research, announces the release of the ViaPlex™ 2-Color Cell Barcoding Kit. Combining fluorescent staining with two [...]

Stockholm, Sweden -- Epigenica AB, a company commercializing advanced tools for epigenetic analysis, today announced a distribution agreement with PrimeTech Co., Ltd., a leading distributor of life science technologies in Japan. The partnership will bring Epigenica’s EpiFinder™ technologies to researchers and laboratories across the Japanese market. Japan represents one of the world’s most advanced life science [...]

Genovis AB, a leading provider of innovative enzyme technologies, today announces a strategic partnership with Single Cell Discoveries to broaden the application of the SEQURNA® Thermostable RNase Inhibitor across advanced single-cell and bulk RNA-sequencing workflows. The collaboration brings together Genovis’ expertise in developing high-performance molecular tools and Single Cell Discoveries’ extensive experience in RNA sequencing [...]

Instem, a global leader in SaaS solutions for life sciences R&D, today announced a 5-year extension of its Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA). (Q)SAR models must be continually updated and validated to remain relevant as new compound classes and chemistries advance through pharmaceutical drug development. At the same [...]

The Gene Therapy Vector Facility at King’s College London announced the addition of the Univercells Technologies’ scale-X™ carbo bioreactor to its GMP manufacturing portfolio The Gene Therapy Vector Facility at King’s College London announced the addition of the Univercells Technologies’ scale-X™ carbo bioreactor to its GMP manufacturing portfolio, further strengthening our capabilities for adeno associated [...]

North Brunswick, NJ – Distek, Inc., a leading manufacturer of pharmaceutical laboratory instrumentation, announced the launch of its new Online Instrument Configurator, a web-based tool designed to simplify instrument configuration and accelerate quote requests for pharmaceutical laboratories worldwide. The tool enables users to build detailed instrument configurations and submit them directly to Distek as a quote [...]

LONDON, UK -- Touchlight, in collaboration with New England Biolabs (NEB®), announces the launch of the EnClose™ Cell-free dbDNA™ Synthesis Kit, a new benchtop solution enabling rapid enzymatic production of Touchlight’s proprietary doggybone DNA™ (dbDNA™). This linear, covalently closed, double-stranded DNA format offers researchers a fast, cell-free alternative to traditional plasmid DNA, supporting the growing demand for nucleic acid [...]

London & Minneapolis – Cenevo’s Labguru platform is delivering a comprehensive solution to centralize documentation processes at Pace® Life Sciences, a U.S.-based contract development and manufacturing organization (CDMO) and full-service good manufacturing practice (GMP) analytical laboratory service provider.   Labguru is an all-in-one cloud-based laboratory data management research-to-production platform, combining an electronic lab notebook (ELN), inventory management, registration, laboratory information management [...]

SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration to advance precision oncology through innovative applications of next-generation sequencing (NGS) solutions across the healthcare ecosystem. Projects are expected to include promoting equitable access to cancer biomarker testing by bringing it [...]